The Enterprise Value as of September 2024 (TTM) for Silo Pharma, Inc. (SILO) is 404.18K

According to Silo Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 404.18K. This represents a change of -76.67% compared to the average of 1.73M of the last 4 quarters.

Silo Pharma, Inc. (SILO) Historical Enterprise Value (quarterly & annually)

How has SILO Enterprise Value performed in the past?

The mean historical Enterprise Value of Silo Pharma, Inc. over the last ten years is 11.42M. The current 404.18K Enterprise Value has changed 253.95% with respect to the historical average. Over the past ten years (40 quarters), SILO's Enterprise Value was at its highest in in the September 2020 quarter at 27.92M. The Enterprise Value was at its lowest in in the June 2024 quarter at -1502476.66.

Silo Pharma, Inc. (SILO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Silo Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Silo Pharma, Inc. (SILO) Average Enterprise Value

How has SILO Enterprise Value performed in the past?

The current Enterprise Value of Silo Pharma, Inc. (SILO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Silo Pharma, Inc. (SILO) Enterprise Value vs. Peers

How is SILO’s Enterprise Value compared to its peers?

Silo Pharma, Inc.’s Enterprise Value is less than Protagenic Therapeutics, Inc. (2.65M), less than Rezolute, Inc. (282.64M), less than Lumos Pharma, Inc. (21.05M), less than Anebulo Pharmaceuticals, Inc. (49.05M), less than Sino Biopharmaceutical Limited (10.13B), less than Inventiva S.A. (114.51M), less than BioCardia, Inc. (9.38M), less than UroGen Pharma Ltd. (436.67M), less than Indaptus Therapeutics, Inc. (9.04M), less than Tempest Therapeutics, Inc. (23.17M), greater than Comera Life Sciences Holdings, Inc. (-913895.00), less than Forte Biosciences, Inc. (1.13M), less than Pardes Biosciences, Inc. (34.92M), less than Shattuck Labs, Inc. (117.81M), less than Eliem Therapeutics, Inc. (330.21M), less than Champions Oncology, Inc. (74.49M), less than Century Therapeutics, Inc. (150.46M), less than Acumen Pharmaceuticals, Inc. (112.86M), less than HOOKIPA Pharma Inc. (91.96M), less than Day One Biopharmaceuticals, Inc. (976.06M), less than Inozyme Pharma, Inc. (407.88M), less than Terns Pharmaceuticals, Inc. (574.12M),

Build a custom stock screener for Silo Pharma, Inc. (SILO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Silo Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Silo Pharma, Inc. (SILO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Silo Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.